Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Demonstrates State-Of-The-Art ESR Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instruments and medical devices for the healthcare industry at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany. More...

At MEDICA 2022, ALCOR is presenting iSED, a 20-position, fully automated ESR analyzer that produces results in 20 seconds using just 100µL of sample taken directly from the primary EDTA tube. This small sample volume makes the iSED ideal for pediatric and low volume samples. Primary tube sampling ensures sample and result traceability and decreases biohazard risk to the user. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS.

ALCOR is also demonstrating the miniiSED, a single position, fully automated ESR analyzer that uses the same technology as the iSED in a smaller footprint. The miniiSED produces results in just 15 seconds using only 100 µL of sample taken directly from the primary EDTA tube. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS. With the small sample volume and fast turnaround time in a minimal footprint, the miniiSED is the ideal ESR analyzer for small hospital laboratories, emergency rooms, specialty testing laboratories and POLs.

Related Links:
ALCOR Scientific


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.